Tomaralimab Uses, Dosage, Side Effects and more
Tomaralimab is under investigation in clinical trial NCT01794663 (Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function).
| Trade Name | Tomaralimab |
| Generic | Tomaralimab |
| Tomaralimab Other Names | Tomaralimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
